Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013

Journal of Cardiovascular Translational Research

Volumn 7, Issue 5, 2014, Pages 518-525

  Barbato, Emanuele ^a   Lara Pezzi, Enrique ^b,c   Stolen, Craig ^d   Taylor, Angela ^e   Barton, Paul J ^c,f   Bartunek, Jozef ^a   Iaizzo, Paul ^g   Judge, Daniel P ^h   Kirshenbaum, Lorrie ⁱ   Blaxall, Burns C ^j   Terzic, Andre ^k   Hall, Jennifer L ^l  

^a CARDIOVASCULAR CENTER   (Belgium)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d BOSTON SCIENTIFIC CORPORATION   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g UNIVERSITY OF MINNESOTA   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^j CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^k MAYO CLINIC   (United States)

^l UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

more..

Author keywords

Anatomy; Antiplatelet; Aortic valve; Atrial fibrillation; Biomarker; Genetic; Genomic; Heart failure; Imaging; Induced pluripotent stem cell; Mitral valve; Platelet; TAVR

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CAPLACIZUMAB; CONNECTIVE TISSUE GROWTH FACTOR; HEART AND NEURAL CREST DERIVATIVES EXPRESSED 2 PROTEIN; KRUPPEL LIKE FACTOR 4; LONG UNTRANSLATED RNA; MADS BOX TRANSCRIPTION ENHANCER FACTOR 2 POLYPEPTIDE C; MICRORNA; MICRORNA 15; MYC PROTEIN; MYOCARDIN; OCTAMER TRANSCRIPTION FACTOR 4; PLACEBO; THROMBIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR MYELOID ZINC FINGER 1; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TBX5; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VORAPAXAR;

ACTION POTENTIAL; ACUTE CORONARY SYNDROME; ALTERNATIVE RNA SPLICING; ANTICOAGULANT THERAPY; AORTA STENOSIS; BLOOD PRESSURE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; COMPUTED TOMOGRAPHY SCANNER; CORONARY ARTERY PRESSURE; CORONARY FLOW RESERVE; DOPPLER ECHOCARDIOGRAPHY; DRUG ACTIVITY; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG TARGETING; FIBROBLAST; FRACTIONAL FLOW RESERVE; GENE EXPRESSION REGULATION; GENE PRODUCT; GENE REGULATORY NETWORK; GENOMICS; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HOMEOSTASIS; HUMAN; HYPERTENSION; LONG QT SYNDROME; MEDICAL RESEARCH; MICROBUBBLE; MITRAL VALVE REGURGITATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL PERFUSION IMAGING; NONHUMAN; NUCLEAR REPROGRAMMING; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHENOTYPE; PLEIOTROPY; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; PTCA CATHETER; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSCATHETER VALVE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ANIMAL; BLOOD; CARDIOLOGY; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; FOOD AND DRUG ADMINISTRATION; GENETICS; METABOLISM; PHYSIOLOGY; PUBLICATION; TRANSLATIONAL RESEARCH; TRANSPLANTATION; TRENDS; UNITED STATES;

ANIMALS; BIOLOGICAL MARKERS; CARDIOLOGY; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; GENOMICS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PERIODICALS AS TOPIC; PLATELET AGGREGATION INHIBITORS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84904402001     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-014-9555-7     Document Type: Review

References (64)

1. Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872. (Pubitemid 350138099)
2. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676. (Pubitemid 44233629)
3. Inagawa, K., & Ieda, M. (2013). Direct reprogramming of mouse fibroblasts into cardiac myocytes. Journal of Cardiovascular Translational Research, 6, 37-45.
4. Folmes, C. D., Martinez-Fernandez, A., Faustino, R. S., et al. (2013). Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. Journal of Cardiovascular Translational Research, 6, 10-21.
5. Itzhaki, I., Maizels, L., Huber, I., et al. (2011). Modelling the long QT syndrome with induced pluripotent stem cells. Nature, 471, 225-229.
6. Pasca, S. P., Portmann, T., Voineagu, I., et al. (2011). Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nature Medicine, 17, 1657-1662.
7. Sinnecker, D., Goedel, A., Dorn, T., Dirschinger, R. J., Moretti, A., & Laugwitz, K. L. (2013).Modeling long-QTsyndromes with iPS cells. Journal of Cardiovascular Translational Research, 6, 31-36.
8. Braunwald, E. (2009). Hypertrophic cardiomyopathy: the early years. Journal of Cardiovascular Translational Research, 2, 341-348.
9. Gaasch, W. H., & Zile, M. R. (2011). Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. Journal of the American College of Cardiology, 58, 1733-1740.
10. Lunkenheimer, P. P., Niederer, P., Sanchez-Quintana, D., Murillo, M., & Smerup, M. (2013). Models of ventricular structure and function reviewed for clinical cardiologists. Journal of Cardiovascular Translational Research, 6, 176-186.
11. Moreno-Moral, A., Mancini, M., D'Amati, G., Camici, P., & Petretto, E. (2013). Transcriptional network analysis for the regulation of left ventricular hypertrophy and microvascular remodeling. Journal of Cardiovascular Translational Research, 6, 931-944.
12. Petretto, E., Sarwar, R., Grieve, I., et al. (2008). Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nature Genetics, 40, 546-552. (Pubitemid 351601220)
13. Ma, Y., Halade, G. V., & Lindsey, M. L. (2012). Extracellular matrix and fibroblast communication following myocardial infarction. Journal of Cardiovascular Translational Research, 5, 848-857.
14. Panse, K. D., Felkin, L. E., Lopez-Olaneta, M. M., et al. (2012). Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes. Journal of Cardiovascular Translational Research, 5, 814-826.
15. Blaauw, E., Lorenzen-Schmidt, I., Babiker, F. A., et al. (2013). Stretch-induced upregulation of connective tissue growth factor in rabbit cardiomyocytes. Journal of Cardiovascular Translational Research, 6, 861-869.
16. Felkin, L. E., Lara-Pezzi, E. A., Hall, J. L., Birks, E. J.,&Barton, P. J. (2011). Reverse remodelling and recovery from heart failure are associated with complex patterns of gene expression. Journal of Cardiovascular Translational Research, 4, 321-331.
17. Lara-Pezzi, E., Gomez-Salinero, J., Gatto, A., & Garcia-Pavia, P. (2013). The alternative heart: impact of alternative splicing in heart disease. Journal of Cardiovascular Translational Research, 6, 945-955.
18. Wijnen, W. J., Pinto, Y.M., & Creemers, E. E. (2013). The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand? Journal of Cardiovascular Translational Research, 6, 899-908.
19. Papait, R., Kunderfranco, P., Stirparo, G. G., Latronico, M. V., & Condorelli, G. (2013). Long noncoding RNA: a new player of heart failure? Journal of Cardiovascular Translational Research, 6, 876-883.
20. Lara-Pezzi, E., Dopazo, A., & Manzanares, M. (2012). Understanding cardiovascular disease: a journey through the genome (and what we found there). Disease models & mechanisms, 5, 434-443.
21. Porrello, E. R., Mahmoud, A. I., Simpson, E., et al. (2011). Transient regenerative potential of the neonatal mouse heart. Science, 331, 1078-1080.
22. Senyo, S. E., Steinhauser, M. L., Pizzimenti, C. L., et al. (2013). Mammalian heart renewal by pre-existing cardiomyocytes. Nature, 493, 433-436.
23. Beltrami, A. P., Barlucchi, L., Torella, D., et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114, 763-776. (Pubitemid 37186770)
24. Chong, J. J., Chandrakanthan, V., Xaymardan, M., et al. (2011). Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell, 9, 527-540.
25. Smart, N., Bollini, S., Dube, K. N., et al. (2011). De novo cardiomyocytes from within the activated adult heart after injury. Nature, 474, 640-644.
26. Bernal, J. A. (2013). RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. Journal of Cardiovascular Translational Research, 6, 956-968.
27. Menghini, R., Casagrande, V.,& Federici, M. (2013). MicroRNAs in endothelial senescence and atherosclerosis. Journal of Cardiovascular Translational Research, 6, 924-930.
28. Deddens, J. C., Colijn, J. M., Oerlemans, M. I., et al. (2013). Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. Journal of Cardiovascular Translational Research, 6, 884-898.
29. Lee, R. G., Crosby, J., Baker, B. F., Graham, M. J., & Crooke, R. M. (2013). Antisense technology: an emerging platform for cardiovascular disease therapeutics. Journal of Cardiovascular Translational Research, 6, 969-980.
30. Van Aelst, L. N., & Heymans, S. (2013). MicroRNAs as biomarkers for ischemic heart disease. Journal of Cardiovascular Translational Research, 6, 458-470.
31. Hudson, J. E.,& Porrello, E. R. (2013). The non-coding road towards cardiac regeneration. Journal of Cardiovascular Translational Research, 6, 909-923.
32. Eulalio, A., Mano, M., Dal Ferro, M., et al. (2012). Functional screening identifies miRNAs inducing cardiac regeneration. Nature, 492, 376-381.
33. Chen, J., Huang, Z. P., Seok, H. Y., et al. (2013). mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circulation Research, 112, 1557-1566.
34. Hu, S., Huang, M., Nguyen, P. K., et al. (2011). Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation, 124, S27-S34.
35. Sluijter, J. P., van Mil, A., van Vliet, P., et al. (2010). MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arteriosclerosis Thrombosis and Vascular Biology, 30, 859-868.
36. Fu, J. D., Rushing, S. N., Lieu, D. K., et al. (2011). Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PloS one, 6, e27417.
37. Ivey, K. N., Muth, A., Arnold, J., et al. (2008). MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell, 2, 219-229. (Pubitemid 351298595)
38. Zhou, Q., Gallagher, R., Ufret-Vincenty, R., Li, X., Olson, E. N., & Wang, S. (2011). Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23 27 24 clusters. Proceedings of the National Academy of Sciences of the United States of America, 108, 8287-8292.
39. Jayawardena, T. M., Egemnazarov, B., Finch, E. A., et al. (2012). MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circulation Research, 110, 1465-1473.
40. Hartupee, J., & Mann, D. L. (2013). Positioning of inflammatory biomarkers in the heart failure landscape. Journal of Cardiovascular Translational Research, 6, 485-492.
41. De, A., Meier, K., Tang, R., et al. (2013). Evaluation of heart failure biomarker tests: a survey of statistical considerations. Journal of Cardiovascular Translational Research, 6, 449-457.
42. Bateman, M. G., Hill, A. J., Quill, J. L., & Iaizzo, P. A. (2013). The clinical anatomy and pathology of the human arterial valves: implications for repair or replacement. Journal of Cardiovascular Translational Research, 6, 166-175.
43. Ragosta, M. (2013). Multi-modality imaging of the aortic valve in the era of transcatheter aortic valve replacement: a guide for patient selection, valve selection, and valve delivery. Journal of Cardiovascular Translational Research, 6, 665-674.
44. Bateman, M. G., Quill, J. L., Hill, A. J., & Iaizzo, P. A. (2013). The clinical anatomy and pathology of the human atrioventricular valves: implications for repair or replacement. Journal of Cardiovascular Translational Research, 6, 155-165.
45. Lim, D. S. (2013). Using imaging to guide patient selection and performance of catheter-based mitral valve repair for mitral regurgitation. Journal of Cardiovascular Translational Research, 6, 675-680.
46. Loukas, M., Sharma, A., Blaak, C., Sorenson, E., &Mian, A. (2013). The clinical anatomy of the coronary arteries. Journal of Cardiovascular Translational Research, 6, 197-207.
47. Zarins, C. K., Taylor, C. A., & Min, J. K. (2013). Computed fractional flow reserve (FFTCT) derived from coronary CTangiography. Journal of Cardiovascular Translational Research, 6, 708-714.
48. Patel, A. R., Bhave, N. M., & Mor-Avi, V. (2013). Myocardial perfusion imaging with cardiac computed tomography: state of the art. Journal of Cardiovascular Translational Research, 6, 695-707.
49. Ng, V. G., Meller, S., Shetty, S., & Lansky, A. J. (2013). Diagnosing and characterizing coronary artery disease in women: developments in noninvasive and invasive imaging techniques. Journal of Cardiovascular Translational Research, 6, 740-751.
50. Gan, L. M., Wikstrom, J., & Fritsche-Danielson, R. (2013). Coronary flow reserve from mouse to man - from mechanistic understanding to future interventions. Journal of Cardiovascular Translational Research, 6, 715-728.
51. Davies, M. J. (1998). Reactive oxygen species, metalloproteinases, and plaque stability. Circulation, 97, 2382-2383.
52. Falk, E., Shah, P. K., & Fuster, V. (1995). Coronary plaque disruption. Circulation, 92, 657-671.
53. Naghavi, M., Libby, P., Falk, E., et al. (2003). From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation, 108, 1664-1672. (Pubitemid 37243650)
54. Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000). Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis Thrombosis and Vascular Biology, 20, 1262-1275. (Pubitemid 30262927)
55. Nair, A., Kuban, B. D., Tuzcu, E.M., Schoenhagen, P., Nissen, S.E., & Vince, D. G. (2002). Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation, 106, 2200-2206. (Pubitemid 35222213)
56. Vazquez-Figueroa, J. G., Rinehart, S., Qian, Z., et al. (2013). Prospective validation that vulnerable plaque associated with major adverse outcomes have larger plaque volume, less dense calcium, and more non-calcified plaque by quantitative, three-dimensional measurements using intravascular ultrasound with radiofrequency backscatter analysis: results from the ATLANTA I study. Journal of Cardiovascular Translational Research, 6, 762-771.
57. Verjans, J. W., & Jaffer, F. A. (2013). Biological imaging of atherosclerosis: moving beyond anatomy. Journal of Cardiovascular Translational Research, 6, 681-694.
58. Lindner, J. R., Song, J., Jayaweera, A. R., Sklenar, J., & Kaul, S. (2002). Microvascular rheology of Definity microbubbles after intraarterial and intravenous administration. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography, 15, 396-403.
59. Klibanov, A. L. (2013). Ultrasound contrast materials in cardiovascular medicine: from perfusion assessment to molecular imaging. Journal of Cardiovascular Translational Research, 6, 729-739.
60. Bartunek, J., Barbato, E., Heyndrickx, G., Vanderheyden, M., Wijns, W., & Holz, J. B. (2013). Novel antiplatelet agents: ALX-0081, a nanobody directed towards von Willebrand factor. Journal of Cardiovascular Translational Research, 6, 355-363.
61. Muller, O., Bartunek, J., Hamilos, M., et al. (2013). von Willebrand factor inhibition improves endothelial function in patients with stable angina. Journal of Cardiovascular Translational Research, 6, 364-370.
62. Cimmino, G., & Golino, P. (2013). Platelet biology and receptor pathways. Journal of Cardiovascular Translational Research, 6, 299-309.
63. de Souza, B. F.,& Tricoci, P. (2013). Novel anti-platelet agents: focus on thrombin receptor antagonists. Journal of Cardiovascular Translational Research, 6, 415-424.
64. Guo, Y., Lip, G. Y., & Apostolakis, S. (2013). The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure. Journal of Cardiovascular Translational Research, 6, 388-397.